Key Developments

On April 17, 2024, Siemens Healthineers, a medical device company, announced that it had launched Mammomat B.brilliant1, a new tomosynthesis mammography system with a wide-angle tube that moves around the breast at a 50° angle and a scan time of around five seconds, creating a 3D image with high depth resolution in the shortest time possible. The system enables abnormalities and microcalcifications in the tissue to be identified with a high level of accuracy.
In November 2023, University of Rochester Medical Center Rochester, U.S. launched Mobile Mammography Van, equipped with state-of-the-art, 3D breast imaging technology. It provides important preventive care for women throughout the Rochester, Finger Lakes, and Western New York region in the U.S.
In November 2023, GE Healthcare, a healthcare company, announced the launch of MyBreastAI Suit, an all-in-one platform of artificial intelligence (AI) app to support clinicians with breast cancer detection and improved workflow productivity. MyBreastAI Suite integrates three artificial intelligence (AI) applications from iCAD including ProFound AI for DBT, SecondLook for 2D Mammography and PowerLook Density Assessment to help support early detection and improve patient outcomes, as well as help radiology departments improve operational productivity.
In March 2021, the World Health Organization (WHO), in collaboration with the International Agency for Research on Cancer (IARC) and the International Atomic Energy Agency (IAEA), launched the Global Breast Cancer Initiative. The Global Breast Cancer Initiative will focus efforts on the potential of multisectoral partnerships, programmes that promote sustainable capacity-building, and innovation and monitoring systems that use data for decision-making.
In December 2020, Hologic Inc., a medical technology company primarily focused on improving women’s health, announced the U.S. Food and Drug Administration (FDA) clearance and commercial availability of the Genius AI Detection technology, a new deep learning-based software designed to help radiologists detect subtle potential cancers in breast tomosynthesis images.
In October 2020, Siemens Healthineers, a medical device company, received clearance from the U.S. Food and Drug Administration (FDA) for Ysio Max digital radiography system which includes new detectors and usability features that improve imaging and speed up exams